Suppr超能文献

每日两次与每日三次治疗平衡系统紊乱的疗效相当

[Comparable efficacy between twice and three times daily for treatment of balance system disturbances].

作者信息

Jurkiewicz Dariusz, Kantor Ireneusz

机构信息

Wojskowy Instytut Medyczny w Warszawie, CSK MON, Klinika Otolaryngologiczna.

出版信息

Pol Merkur Lekarski. 2009 Jan;26(151):29-34.

Abstract

UNLABELLED

In spite of detailed examinations it is impossible to find reasons for balance system disturbances in more than 25 per cent of patients. Therefore doctors have to treat symptoms but not the reasons for balance system disturbances. One of the most frequently administered medicine in treatment of both central and peripheral balance system disturbances is betahistine dihydrochloride (Betaserc). The aim of the study was to evaluate the influence of Betaserc an balance system disturbances with reference to dosage.

MATERIAL AND METHODS

Patients were divided into two groups. The first group (Group I) was treated with Betaserc three times a day: 16 mg for minimum 4 weeks and 8 mg for minimum 8 weeks. The second group (Group II) was treated with Betaserc twice a day: 24 mg for maximum 4 weeks and next 12 mg for minimum 8 weeks. The data from interviews and additional examinations (videonystagmography and posturography) were considered.

RESULTS

The latter group more often showed smaller balance system disturbances and vertigo than the first group both after 4 and 12 weeks. After 12 weeks of treatment more patients from the second group reported "a complete disappearance" of the symptoms. A substantial improvement of results was observed in videonystagmography and posturography examinations.

CONCLUSION

The treatment with 24 mg for 4 weeks and 12 mg for 8 weeks twice daily was better tolerated and gave higher positive effects than the treatment three times a day with 16 mg for 4 weeks and 8 mg for 8 weeks.

摘要

未标注

尽管进行了详细检查,但仍有超过25%的患者无法找到平衡系统紊乱的原因。因此,医生不得不治疗症状而非平衡系统紊乱的原因。在治疗中枢性和外周性平衡系统紊乱时,最常用的药物之一是倍他司汀二盐酸盐(敏使朗)。本研究的目的是评估敏使朗对平衡系统紊乱的影响,并参考剂量。

材料与方法

患者分为两组。第一组(I组)每天服用敏使朗三次:16毫克,至少服用4周,然后8毫克,至少服用8周。第二组(II组)每天服用敏使朗两次:24毫克,最多服用4周,然后12毫克,至少服用8周。考虑了访谈数据和额外检查(视频眼震图和姿势描记法)的数据。

结果

在4周和12周后,后一组比第一组更常出现较小的平衡系统紊乱和眩晕。治疗12周后,第二组更多患者报告症状“完全消失”。在视频眼震图和姿势描记法检查中观察到结果有显著改善。

结论

与每天三次服用16毫克4周和8毫克8周的治疗相比,每天两次服用24毫克4周和12毫克8周的治疗耐受性更好,且产生的积极效果更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验